Legato Capital Management LLC lessened its holdings in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) by 23.1% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 11,462 shares of the scientific and technical instruments company’s stock after selling 3,437 shares during the period. Legato Capital Management LLC’s holdings in Transcat were worth $1,212,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. nVerses Capital LLC acquired a new stake in shares of Transcat during the third quarter worth $60,000. SG Americas Securities LLC acquired a new position in shares of Transcat during the 4th quarter worth about $182,000. US Bancorp DE increased its stake in shares of Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock valued at $187,000 after acquiring an additional 209 shares during the last quarter. Captrust Financial Advisors acquired a new stake in shares of Transcat in the 3rd quarter valued at approximately $201,000. Finally, Walleye Capital LLC bought a new position in Transcat during the 3rd quarter worth approximately $216,000. Institutional investors own 98.34% of the company’s stock.
Transcat Price Performance
TRNS stock opened at $81.60 on Thursday. The stock has a 50-day moving average price of $98.80 and a two-hundred day moving average price of $110.56. Transcat, Inc. has a 1 year low of $73.37 and a 1 year high of $147.12. The stock has a market cap of $759.70 million, a PE ratio of 44.11 and a beta of 0.67. The company has a current ratio of 2.42, a quick ratio of 3.00 and a debt-to-equity ratio of 0.14.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on the stock. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. HC Wainwright dropped their price objective on Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Craig Hallum boosted their target price on Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, Northland Securities reiterated a “market perform” rating and issued a $85.00 price objective (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $111.50.
Check Out Our Latest Analysis on Transcat
Insider Transactions at Transcat
In related news, Director Craig D. Cairns acquired 1,200 shares of the firm’s stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the acquisition, the director now directly owns 1,910 shares of the company’s stock, valued at approximately $147,108.20. The trade was a 169.01 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 2.30% of the stock is currently owned by insiders.
Transcat Company Profile
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
- Five stocks we like better than Transcat
- What Are Some of the Best Large-Cap Stocks to Buy?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- How to Invest in Blue Chip Stocks
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Most Effectively Use the MarketBeat Earnings Screener
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.